Correlation Between Mednax and Fulgent Genetics

Can any of the company-specific risk be diversified away by investing in both Mednax and Fulgent Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mednax and Fulgent Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mednax Inc and Fulgent Genetics, you can compare the effects of market volatilities on Mednax and Fulgent Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mednax with a short position of Fulgent Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mednax and Fulgent Genetics.

Diversification Opportunities for Mednax and Fulgent Genetics

0.7

Correlation Coefficient

Mednax  Fulgent Genetics

Poor diversification

The 3 months correlation between Mednax and Fulgent is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Mednax Inc and Fulgent Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fulgent Genetics and Mednax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mednax Inc are associated (or correlated) with Fulgent Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fulgent Genetics has no effect on the direction of Mednax i.e., Mednax and Fulgent Genetics go up and down completely randomly.

Pair Corralation between Mednax and Fulgent Genetics

Allowing for the 90-day total investment horizon Mednax Inc is expected to under-perform the Fulgent Genetics. But the stock apears to be less risky and, when comparing its historical volatility, Mednax Inc is 1.1 times less risky than Fulgent Genetics. The stock trades about -0.11 of its potential returns per unit of risk. The Fulgent Genetics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,856  in Fulgent Genetics on May 8, 2025 and sell it today you would lose (20.00) from holding Fulgent Genetics or give up 1.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mednax Inc  vs.  Fulgent Genetics

Mednax Inc

Risk-Adjusted Performance

Weakest

Over the last 90 days Mednax Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in September 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Fulgent Genetics

Risk-Adjusted Performance

Weakest

Over the last 90 days Fulgent Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Fulgent Genetics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Mednax and Fulgent Genetics

The main advantage of trading using opposite Mednax and Fulgent Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mednax position performs unexpectedly, Fulgent Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulgent Genetics will offset losses from the drop in Fulgent Genetics' long position.

The idea behind Mednax Inc and Fulgent Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.